Navigation Links
JoVE partners with US government to publish cutting-edge defense research
Date:5/15/2012

On May 15, 2012, JoVE (Journal of Visualized Experiments) will publish two articles in partnership with the United States government's Defense Threat Reduction Agency (DTRA). JoVE is proud to present the work from Temple University's Dr. Chris Schafmeister and State University of New York Buffalo's Dr. David Pawlowski and Dr. Richard Karalus.

The support of scientists conducting research for DTRA has significant ramifications for identifying, treating, and preventing the outbreak of defense threats. DTRA exists to safeguard America and its allies from weapons of mass destruction (WMD), including chemical, biological, radiological, nuclear weapons and high-yield explosives (CBRNE), by providing capabilities to reduce, eliminate, and counter the threat and mitigate its effects. Because the techniques and technologies developed in DTRA sponsored laboratories promise a safer world and will benefit from distribution in a highly visual format, DTRA has sponsored the research and publication of their scientists in JoVE.

From Temple University, award winning scientist Dr. Chris Schafmeister, working with Conrad Pfeiffer, developed a biochemical technique that produces new, complex polymers called bis-peptides. Dr. Schafmeister tells us, "The building blocks and the final molecule are special. Our molecules bind with two bonds to each molecule, unlike the typical single bond, making a stiff, ladder-like construct." Dr. Schafmeister won the "Outstanding Scientific Achievement Award" from the Chemical and Biological Defense Science and Technology conference for his work. Dr. Schafmeister, choosing to publish his research in JoVE, notes, "This procedure demonstrates cutting edge capabilities that don't exist anywhere else. Hopefully, they will lead to products in the next decade far beyond anything we can produce right now."

In the second DTRA sponsored JoVE article, Dr. David Pawlowski and his colleague Dr. Richard Karalus publish their procedure on the isolation of nucleic acids and proteins, without electricity or laboratory support. This work has significant implications for real time threat monitoring. Dr. Pawlowski explains, "This is a handheld electricity-free device which can be used in the field by the warfighter, in conjunction with their detection platforms." He continues, stating that this technique will "be useful for detection of typical biological warfare agents." Dr. Pawlowski notes that he and his colleagues were incredibly satisfied with their experience publishing in this format. "My reason for publishing this in JoVE is that a video article offered us the opportunity to provide a visualization of this small, handheld tool. Giving a simple, verbal description is difficult, so a JoVE publication helps with training the warfighters how to use the technique."

JoVE is proud to work with these unique scientists and to support DTRA's mission. Dr. Nandita Singh, Senior Science Editor at JoVE, attended the annual Chemical and Biological Defense Science and Technology Conference, this past November, where she encountered the wide variety of research funded by DTRA. She notes, "The research funded by DTRA is very cutting edge and exciting. I look forward to our partnership because the JoVE format will allow the scientific community to accurately replicate the methodologies developed by DTRA funding. This partnership poses a unique opportunity for JoVE to help support military services and their allies in an effort to promote counterproliferation, nonproliferation and WMD reduction issues. Carl Brown Sr., DTRA Staff Director for Strategic Communication & Outreach says, for DTRA, this partnership is ideal, as "it is essential that the national security and scientific communities leverage efforts and activities to maximize global health security."


'/>"/>

Contact: Neal Moawed
neal.moawed@jove.com
617-245-0137
The Journal of Visualized Experiments
Source:Eurekalert  

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
3. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
4. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
5. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
6. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
7. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
8. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
9. Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
10. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
11. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
JoVE partners with US government to publish cutting-edge defense research
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... 23, 2016 , ... In a new case report published today in STEM ... who developed lymphedema after being treated for breast cancer benefitted from an injection of ... dealing with this debilitating, frequent side effect of cancer treatment. , Lymphedema ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
Breaking Biology News(10 mins):